Novartis Europharm Ltd
102 products tracked · names used in filings: Novartis Europharm Ltd, Novartis Europharm Ltd., Novartis Europharm Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 15 Jul 2026🇪🇺 EU approval (EC decision)
Vijoice (alpelisib) approved in the EU
Marketing authorisation to Novartis Europharm Limited; Orphan, Conditional, Additional monitoring · source
Tue 30 Jun 2026🇪🇺 EU approval (EC decision)
Itvisma (onasemnogene abeparvovec) approved in the EU
Marketing authorisation to Novartis Europharm Limited; Additional monitoring · source
Thu 21 May 2026🇪🇺 CHMP positive opinion
Vijoice (alpelisib): CHMP positive opinion
Novartis Europharm Limited; Orphan, Conditional, Additional monitoring · source
Thu 23 Apr 2026🇪🇺 CHMP positive opinion
Itvisma (onasemnogene abeparvovec): CHMP positive opinion
Novartis Europharm Limited; Additional monitoring · source
Thu 23 Apr 2026🇪🇺 EU approval (EC decision)
Rhapsido (remibrutinib) approved in the EU
Marketing authorisation to Novartis Europharm Limited; Additional monitoring · source
Thu 26 Feb 2026🇪🇺 CHMP positive opinion
Rhapsido (remibrutinib): CHMP positive opinion
Novartis Europharm Limited; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Vijoice alpelisib | Application withdrawn | |
| 🇪🇺 | Ruvise imatinib | Application withdrawn | |
| 🇪🇺 | Reasanz serelaxin | Refused | |
| 🇪🇺 | Canakinumab Novartis canakinumab | Application withdrawn | |
| 🇪🇺 | Xiidra Lifitegrast | Application withdrawn | |
| 🇪🇺 | Zelnorm tegaserod | Refused | |
| 🇪🇺 | Joulferon | Application withdrawn | |
| 🇪🇺 | Rasival | Application withdrawn | |
| 🇪🇺 | Vijoice alpelisib | Authorised | 2026-07-15 |
| 🇪🇺 | Itvisma onasemnogene abeparvovec | Authorised | 2026-06-30 |
| 🇪🇺 | Rhapsido remibrutinib | Authorised | 2026-04-23 |
| 🇪🇺 | Fabhalta iptacopan | Authorised | 2024-05-17 |
| 🇪🇺 | Spexotras trametinib | Authorised | 2024-01-05 |
| 🇪🇺 | Finlee dabrafenib | Authorised | 2023-11-15 |
| 🇪🇺 | Locametz gozetotide | Authorised | 2022-12-09 |
| 🇪🇺 | Pluvicto lutetium (177Lu) vipivotide tetraxetan | Authorised | 2022-12-09 |
| 🇪🇺 | Scemblix asciminib | Authorised | 2022-08-25 |
| 🇪🇺 | Tabrecta capmatinib | Authorised | 2022-06-20 |
| 🇪🇺 | Kesimpta ofatumumab | Authorised | 2021-03-26 |
| 🇪🇺 | Leqvio inclisiran | Authorised | 2020-12-09 |
| 🇪🇺 | Adakveo crizanlizumab | Revoked | 2020-10-28 |
| 🇪🇺 | Piqray alpelisib | Authorised | 2020-07-27 |
| 🇪🇺 | Zimbus Breezhaler indacaterol;glycopyrronium;mometasone furoate | Authorised | 2020-07-03 |
| 🇪🇺 | Enerzair Breezhaler indacaterol;glycopyrronium bromide;mometasone | Authorised | 2020-07-03 |
| 🇪🇺 | Bemrist Breezhaler indacaterol;mometasone | Authorised | 2020-05-30 |
| 🇪🇺 | Atectura Breezhaler indacaterol;mometasone | Authorised | 2020-05-30 |
| 🇪🇺 | Zolgensma onasemnogene abeparvovec | Authorised | 2020-05-18 |
| 🇪🇺 | Beovu brolucizumab | Authorised | 2020-02-13 |
| 🇪🇺 | Mayzent siponimod | Authorised | 2020-01-13 |
| 🇪🇺 | LysaKare arginine;lysine | Authorised | 2019-07-25 |
| 🇪🇺 | Luxturna voretigene neparvovec | Authorised | 2018-11-22 |
| 🇪🇺 | Kymriah tisagenlecleucel | Authorised | 2018-08-23 |
| 🇪🇺 | Aimovig erenumab | Authorised | 2018-07-26 |
| 🇪🇺 | Lutathera lutetium (177Lu) oxodotreotide | Authorised | 2017-09-26 |
| 🇪🇺 | Rydapt midostaurin | Authorised | 2017-09-18 |
| 🇪🇺 | Kisqali ribociclib | Authorised | 2017-08-22 |
| 🇪🇺 | SomaKit TOC edotreotide | Authorised | 2016-12-08 |
| 🇪🇺 | Neparvis sacubitril;valsartan | Authorised | 2016-05-26 |
| 🇪🇺 | Entresto sacubitril;valsartan | Authorised | 2015-11-19 |
| 🇪🇺 | Zykadia ceritinib | Authorised | 2015-05-06 |
| 🇪🇺 | Cosentyx secukinumab | Authorised | 2015-01-14 |
| 🇪🇺 | Simbrinza brinzolamide;brimonidine tartrate | Authorised | 2014-07-18 |
| 🇪🇺 | Mekinist trametinib | Authorised | 2014-06-30 |
| 🇪🇺 | Ulunar Breezhaler indacaterol;glycopyrronium bromide | Authorised | 2014-04-23 |
| 🇪🇺 | Izba travoprost | Authorised | 2014-02-20 |
| 🇪🇺 | Ultibro Breezhaler indacaterol;glycopyrronium bromide | Authorised | 2013-09-19 |
| 🇪🇺 | Xoterna Breezhaler indacaterol;glycopyrronium bromide | Authorised | 2013-09-18 |
| 🇪🇺 | Tafinlar dabrafenib | Authorised | 2013-08-26 |
| 🇪🇺 | Seebri Breezhaler glycopyrronium bromide | Authorised | 2012-09-28 |
| 🇪🇺 | Tovanor Breezhaler glycopyrronium bromide | Authorised | 2012-09-28 |
| 🇪🇺 | Enurev Breezhaler glycopyrronium bromide | Withdrawn | 2012-09-28 |
| 🇪🇺 | Jakavi ruxolitinib | Authorised | 2012-08-23 |
| 🇪🇺 | Rasitrio aliskiren;amlodipine;hydrochlorothiazide | Withdrawn | 2011-11-22 |
| 🇪🇺 | Votubia everolimus | Authorised | 2011-09-02 |
| 🇪🇺 | Sprimeo HCT aliskiren;hydrochlorothiazide | Withdrawn | 2011-06-23 |
| 🇪🇺 | Rasilamlo aliskiren hemifumarate;amlodipine besilate | Withdrawn | 2011-04-14 |
| 🇪🇺 | Riprazo HCT aliskiren;hydrochlorothiazide | Withdrawn | 2011-04-13 |
| 🇪🇺 | Gilenya fingolimod | Authorised | 2011-03-17 |
| 🇪🇺 | Votrient pazopanib | Authorised | 2010-06-14 |
| 🇪🇺 | Arzerra ofatumumab | Withdrawn | 2010-04-19 |
| 🇪🇺 | Revolade eltrombopag | Authorised | 2010-03-11 |
| 🇪🇺 | Hirobriz Breezhaler indacaterol | Withdrawn | 2009-11-30 |
| 🇪🇺 | Onbrez Breezhaler indacaterol | Authorised | 2009-11-29 |
| 🇪🇺 | Oslif Breezhaler indacaterol | Withdrawn | 2009-11-29 |
| 🇪🇺 | Dafiro HCT amlodipine besilate;valsartan;hydrochlorothiazide | Authorised | 2009-11-03 |
| 🇪🇺 | Copalia HCT amlodipine;valsartan;hydrochlorothiazide | Authorised | 2009-11-03 |
| 🇪🇺 | Ilaris canakinumab | Authorised | 2009-10-23 |
| 🇪🇺 | Exforge HCT amlodipine besilate;valsartan;hydrochlorothiazide | Authorised | 2009-10-15 |
| 🇪🇺 | Imprida HCT amlodipine;valsartan;hydrochlorothiazide | Lapsed | 2009-10-15 |
| 🇪🇺 | Afinitor everolimus | Authorised | 2009-08-02 |
| 🇪🇺 | Icandra (previously Vildagliptin / metformin hydrochloride Novartis) vildagliptin;metformin | Authorised | 2008-11-30 |
| 🇪🇺 | Zomarist vildagliptin;metformin | Authorised | 2008-11-30 |
| 🇪🇺 | Azarga brinzolamide;timolol | Authorised | 2008-11-25 |
| 🇪🇺 | Xiliarx vildagliptin | Authorised | 2008-11-19 |
| 🇪🇺 | Jalra vildagliptin | Authorised | 2008-11-19 |
| 🇪🇺 | Tyverb lapatinib | Authorised | 2008-06-10 |
| 🇪🇺 | Extavia interferon beta-1b | Withdrawn | 2008-05-20 |
| 🇪🇺 | Nevanac nepafenac | Authorised | 2007-12-11 |
| 🇪🇺 | Tasigna nilotinib | Authorised | 2007-11-19 |
| 🇪🇺 | Eucreas vildagliptin;metformin | Authorised | 2007-11-14 |
| 🇪🇺 | Galvus vildagliptin | Authorised | 2007-09-25 |
| 🇪🇺 | Riprazo aliskiren | Withdrawn | 2007-08-22 |
| 🇪🇺 | Sprimeo aliskiren | Withdrawn | 2007-08-22 |
| 🇪🇺 | Enviage aliskiren | Withdrawn | 2007-08-22 |
| 🇪🇺 | Tekturna aliskiren | Withdrawn | 2007-08-22 |
| 🇪🇺 | Sebivo telbivudine | Withdrawn | 2007-04-24 |
| 🇪🇺 | Lucentis ranibizumab | Authorised | 2007-01-22 |
| 🇪🇺 | Imprida amlodipine;valsartan | Withdrawn | 2007-01-17 |
| 🇪🇺 | Exforge amlodipine;valsartan | Authorised | 2007-01-16 |
| 🇪🇺 | Copalia amlodipine;valsartan | Authorised | 2007-01-15 |
| 🇪🇺 | Dafiro amlodipine;valsartan | Authorised | 2007-01-15 |
| 🇪🇺 | Exjade deferasirox | Authorised | 2006-08-28 |
| 🇪🇺 | DuoTrav travoprost;timolol | Authorised | 2006-04-23 |
| 🇪🇺 | Xolair omalizumab | Authorised | 2005-10-25 |
| 🇪🇺 | Opatanol olopatadine | Authorised | 2002-05-16 |
| 🇪🇺 | Travatan travoprost | Authorised | 2001-11-27 |
| 🇪🇺 | Glivec imatinib | Authorised | 2001-11-07 |
| 🇪🇺 | Starlix nateglinide | Withdrawn | 2001-04-03 |
| 🇪🇺 | Trazec nateglinide | Lapsed | 2001-04-03 |
| 🇪🇺 | Azopt brinzolamide | Authorised | 2000-03-09 |
| 🇪🇺 | Simulect basiliximab | Authorised | 1998-10-09 |
| 🇪🇺 | Exelon rivastigmine | Authorised | 1998-05-11 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.